| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |